Form 4: MeiraGTx CFO Richard Giroux Sells 24,000 Shares Under 10b5-1 Trading Plan

Richard Giroux, CFO & COO of MeiraGTx Holdings plc, sold 24,000 ordinary shares at an average price of $6, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 22, 2025, Richard Giroux, the CFO & COO of MeiraGTx Holdings plc, sold 24,000 ordinary shares of the company.
• The sale was executed under a Rule 10b5-1 trading plan adopted on August 29, 2024.
• The shares were sold at prices ranging from $5.795 to $6.23, with a weighted average sales price of $6.
• Following the transaction, Giroux directly owns 882,494 ordinary shares.
• Giroux also indirectly owns 5,152 shares through his spouse and 85,000 shares through Aigle Healthcare Partners III LLC.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, reporting an insider sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Insider sales are a common occurrence in publicly traded companies. The use of a 10b5-1 trading plan allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information. Investors often monitor insider transactions for signals about a company's prospects, although sales under 10b5-1 plans are generally less informative than discretionary trades.

Comparison to Industry Standards

• It's common for executives at publicly traded companies, such as Amgen, Biogen, and Gilead Sciences, to utilize 10b5-1 trading plans for selling company stock.
• The volume of shares sold (24,000) is relatively small compared to the total outstanding shares of MeiraGTx, suggesting it's unlikely to have a significant impact on the stock price.
• The reported price range of $5.795 to $6.23 is within a normal trading range for a company like MeiraGTx, indicating no unusual price volatility associated with the sale.

Stakeholder Impact

• The sale of shares by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
• The impact on employees, customers, suppliers, and creditors is likely to be minimal, as this is a routine transaction.

Key Dates

Keywords

MeiraGTx, MGTX, Richard Giroux, Form 4, insider trading, Rule 10b5-1, share sale, CFO, COO